Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Turbuhaler

Background: Easyhaler(®) device-metered dry powder inhaler containing budesonide and formoterol fumarate dihydrate (hereafter formoterol) for the treatment of asthma and chronic obstructive pulmonary disease has been developed. The current approvals of the product in Europe were based on several pha...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Aerosol Med Pulm Drug Deliv
Autori principali: Lähelmä, Satu, Sairanen, Ulla, Haikarainen, Jussi, Korhonen, Jani, Vahteristo, Mikko, Fuhr, Rainard, Kirjavainen, Merja
Natura: Artigo
Lingua:Inglês
Pubblicazione: Mary Ann Liebert, Inc. 2015
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4688463/
https://ncbi.nlm.nih.gov/pubmed/25757188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2014.1195
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi